530 related articles for article (PubMed ID: 26237517)
1. Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy.
Chal J; Oginuma M; Al Tanoury Z; Gobert B; Sumara O; Hick A; Bousson F; Zidouni Y; Mursch C; Moncuquet P; Tassy O; Vincent S; Miyanari A; Bera A; Garnier JM; Guevara G; Hestin M; Kennedy L; Hayashi S; Drayton B; Cherrier T; Gayraud-Morel B; Gussoni E; Relaix F; Tajbakhsh S; Pourquié O
Nat Biotechnol; 2015 Sep; 33(9):962-9. PubMed ID: 26237517
[TBL] [Abstract][Full Text] [Related]
2. The Path from Pluripotency to Skeletal Muscle: Developmental Myogenesis Guides the Way.
Hicks M; Pyle A
Cell Stem Cell; 2015 Sep; 17(3):255-7. PubMed ID: 26340524
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.
Nik-Ahd F; Bertoni C
Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122
[TBL] [Abstract][Full Text] [Related]
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
5. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro.
Al Tanoury Z; Zimmerman JF; Rao J; Sieiro D; McNamara HM; Cherrier T; Rodríguez-delaRosa A; Hick-Colin A; Bousson F; Fugier-Schmucker C; Marchiano F; Habermann B; Chal J; Nesmith AP; Gapon S; Wagner E; Gupta VA; Bassel-Duby R; Olson EN; Cohen AE; Parker KK; Pourquié O
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260377
[TBL] [Abstract][Full Text] [Related]
6. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
7. Generation of skeletal muscle from transplanted embryonic stem cells in dystrophic mice.
Bhagavati S; Xu W
Biochem Biophys Res Commun; 2005 Jul; 333(2):644-9. PubMed ID: 15946649
[TBL] [Abstract][Full Text] [Related]
8. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.
Merrick D; Stadler LK; Larner D; Smith J
Dis Model Mech; 2009; 2(7-8):374-88. PubMed ID: 19535499
[TBL] [Abstract][Full Text] [Related]
9. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGFβ-dependent pro-fibrotic signaling.
Caputo L; Granados A; Lenzi J; Rosa A; Ait-Si-Ali S; Puri PL; Albini S
Skelet Muscle; 2020 May; 10(1):13. PubMed ID: 32359374
[TBL] [Abstract][Full Text] [Related]
10. Cells of extraembryonic mesodermal origin confer human dystrophin in the mdx model of Duchenne muscular dystrophy.
Kawamichi Y; Cui CH; Toyoda M; Makino H; Horie A; Takahashi Y; Matsumoto K; Saito H; Ohta H; Saito K; Umezawa A
J Cell Physiol; 2010 Jun; 223(3):695-702. PubMed ID: 20162617
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
[TBL] [Abstract][Full Text] [Related]
12. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
Berry SE; Liu J; Chaney EJ; Kaufman SJ
Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
[TBL] [Abstract][Full Text] [Related]
13. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
14. Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle.
Farini A; Sitzia C; Cassinelli L; Colleoni F; Parolini D; Giovanella U; Maciotta S; Colombo A; Meregalli M; Torrente Y
Development; 2016 Feb; 143(4):658-69. PubMed ID: 26884398
[TBL] [Abstract][Full Text] [Related]
15. Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice.
Zhang Y; Zhu Y; Li Y; Cao J; Zhang H; Chen M; Wang L; Zhang C
Hum Mol Genet; 2015 Nov; 24(21):6029-40. PubMed ID: 26264578
[TBL] [Abstract][Full Text] [Related]
16. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
[TBL] [Abstract][Full Text] [Related]
17. The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy.
Mu X; Tang Y; Lu A; Takayama K; Usas A; Wang B; Weiss K; Huard J
Hum Mol Genet; 2015 May; 24(10):2923-37. PubMed ID: 25678553
[TBL] [Abstract][Full Text] [Related]
18. Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy.
Shahriyari M; Islam MR; Sakib SM; Rinn M; Rika A; Krüger D; Kaurani L; Gisa V; Winterhoff M; Anandakumar H; Shomroni O; Schmidt M; Salinas G; Unger A; Linke WA; Zschüntzsch J; Schmidt J; Bassel-Duby R; Olson EN; Fischer A; Zimmermann WH; Tiburcy M
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3106-3121. PubMed ID: 36254806
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-mediated correction of skeletal muscle Ca
Morera C; Kim J; Paredes-Redondo A; Nobles M; Rybin D; Moccia R; Kowala A; Meng J; Garren S; Liu P; Morgan JE; Muntoni F; Christoforou N; Owens J; Tinker A; Lin YY
Neuromuscul Disord; 2022 Dec; 32(11-12):908-922. PubMed ID: 36418198
[TBL] [Abstract][Full Text] [Related]
20. [WEAK COMBINED MAGNETIC FIELDS ADJUSTED TO THE PARAMETRIC RESONANCE FOR Ca2+ INTENSIFY DYSTROPHIN SYNTHESIS IN MDX MICE SKELETAL MUSCLES AFTER CELL THERAPY].
Sokolova AV; Sokolov GV; Mikhailov VM
Tsitologiia; 2016; 58(2):150-5. PubMed ID: 27228662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
